MU
Muhammed Uvaiz Nazumudheen
About Muhammed Uvaiz Nazumudheen
Data last updated:
Muhammed Uvaiz Nazumudheen is a Director at Alverstone Drug House Private Limited (since 2020) and Director at Alizglow Bioscience Private Limited (since 2025). The companies operate in Pharma and FMCG. The largest current company by reported revenue is Alverstone Drug House Private Limited at ₹38.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alverstone Drug House Private Limited U51909KL2020PTC064881 | Director | 08 Oct 2020 | 2020 | ₹38.5 Lakh (FY 2025) | Active |
 Alizglow Bioscience Private Limited U20237KL2025PTC099423 | Director | 20 Dec 2025 | 2025 | Active |
Board colleagues of Muhammed Uvaiz Nazumudheen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rijas Abdulrehman | 08909384 | Alverstone Drug House Private Limited | Director |
| Alfia Fathima | 11441499 | Alizglow Bioscience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muhammed Uvaiz Nazumudheen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muhammed Uvaiz Nazumudheen
Muhammed Uvaiz Nazumudheen currently holds 2 directorships: Alverstone Drug House Private Limited (Director, since 08 Oct 2020, revenue ₹38.5 Lakh (FY 2025)); Alizglow Bioscience Private Limited (Director, since 20 Dec 2025).
Muhammed Uvaiz Nazumudheen was first appointed on 08 Oct 2020 as Director at Alverstone Drug House Private Limited. The most recent appointment on record is 20 Dec 2025 at Alizglow Bioscience Private Limited.
The current boards of Muhammed Uvaiz Nazumudheen's companies include Rijas Abdulrehman (Alverstone Drug House Private Limited), Alfia Fathima (Alizglow Bioscience Private Limited).